Oramed Pharmaceuticals Inc. (ORMP)

3.9 USD+5.12%
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$169.6M
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.1.14Dividend Yield: 6.41%

Oramed Pharmaceuticals Inc. (ORMP) is not among the 30 most-held stocks of the tracked superinvestor set. Price 3.90 USD; market cap $169.6M.

Price & valuation

Prev Close3.71
Open3.7
Day Range3.7 – 4.05
52 Week Range—
Volume—
Avg Volume (3M)—
Market Cap$169.6MSEC 10-Q, 11/11/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.402 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.1.14SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.3.43SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.6.41%SEC 10-K, 12/31/2025 · fiscal year

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Frequently Asked Questions

Which superinvestors own ORMP?

Oramed Pharmaceuticals Inc. (ORMP) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on ORMP bullish or bearish?

ORMP is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.